Background-Marine n-3 polyunsaturated fatty acids may reduce coronary mortality. Previous data in relation to nonfatal coronary disease, however, have been inconsistent, which may be explained by the use of heterogeneous methods to assess the intake of marine n-3 polyunsaturated fatty acids. We investigated the hypothesis that the content of total and individual marine n-3 polyunsaturated fatty acids in adipose tissue is negatively associated with the incidence of acute coronary syndrome (ACS), including both fatal and nonfatal coronary disease. Methods and Results-In the Diet, Cancer and Health, a Danish cohort study, 57 053 subjects were enrolled and had an adipose tissue biopsy taken at inclusion. During a mean follow-up period of 7.6 years, we identified and verified all cases (nϭ1012) with an incident acute coronary syndrome diagnosis, and a random sample of the cohort (nϭ1630) had their fatty acid composition in adipose tissue determined by gas chromatography. We found negative dose-response associations between the content of total marine n-3 polyunsaturated fatty acids and individual n-3 polyunsaturated fatty acids in adipose tissue and the risk of acute coronary syndrome. Comparing men in the highest and lowest quintiles gave a hazard ratio of 0.65 (95% confidence interval, 0.45 to 0.95) for total n-3 polyunsaturated fatty acids and 0.51 (95% confidence interval, 0.36 to 0.73) for docosahexaenoic acid. Nonfatal cases constituted Ͼ86% of cases, and the association was driven primarily by a reduction in the risk of nonfatal acute coronary syndrome. No consistent associations were found among women. Conclusion-Intake of marine n-3 polyunsaturated fatty acids may protect against acute coronary syndrome in men.
M
arine n-3 polyunsaturated fatty acids (PUFAs) have received attention because of their potential beneficial effect on the risk of coronary heart disease (CHD) since Dyerberg et al 1 demonstrated a low incidence of CHD in Greenland Eskimos. This was ascribed to a diet rich in long-chain n-3 PUFAs, in particular eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Since then, observational epidemiological studies [2] [3] [4] [5] [6] [7] [8] [9] [10] and randomized clinical trials [11] [12] [13] [14] [15] have supported a beneficial effect of fish consumption on the risk of CHD, although results have not been uniform. 5-7,16 -18 Several studies have reported that marine n-3 PUFAs have antiatherosclerotic, antithrombotic, antiarrhythmic, and antiinflammatory effects 19, 20 that may help explain a possible beneficial effect on the risk of acute coronary syndrome (ACS), which includes unstable angina pectoris, nonfatal myocardial infarction (MI), and fatal MI.
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Previous observational epidemiological studies have been based mainly on estimates of dietary intake of marine n-3 PUFAs. A major concern is random and systematic measurement error, which may be due to recall bias, variation in food intake over time, and variability in food table data used to translate dietary items into nutrients. Biomarker studies based on the content of EPA and DHA in plasma or red blood cells, which reflects the dietary intake of marine n-3 PUFAs during the preceding weeks, have shown more consistent beneficial effects. 9, 10, [21] [22] [23] The content of marine n-3 PUFAs in adipose tissue is a biomarker of the dietary intake of marine n-3 PUFAs during the preceding 1 to 3 years. 24 -28 We tested the hypothesis that the content of total marine n-3 PUFAs and the individual marine n-3 fatty acids, EPA, DHA, and docosapentaenoic acid (DPA), in adipose tissue is negatively associated with the risk of ACS among healthy subjects.
Methods
Diet, Cancer and Health is a prospective cohort study that has been described in detail elsewhere. 29 Briefly, between 1993 and 1997, 80 996 men and 79 729 women 50 to 64 years of age were invited to participate in the study; 27 178 men and 29 875 women accepted the invitation. Eligible cohort members were all born in Denmark, lived in the urban areas of Copenhagen and Aarhus, and were not, at the time of invitation, registered with a cancer diagnosis in the Danish Cancer Registry. All participants gave written informed consent, and the study was approved by scientific ethics committees and the Danish Data Protection Agency.
An adipose tissue biopsy was taken from the buttocks of all participants using a luer lock system (Terumo, Terumo Corp, Tokyo, Japan) consisting of a needle, a venoject multisample luer adaptor, and an evacuated blood tube, according to the method of Beynen and Katan. 30 Samples were flushed with nitrogen and stored at Ϫ150°C until analysis. When analyzed, biopsies were thawed and adipose tissue was removed to a glass and prewarmed at 50°C for 10 minutes. Subsequently, the fat was dissolved in heptane at 50°C, and fatty acids were transesterified by 2 mol/L KOH in methanol at 50°C for 2 minutes, according to the International Union of Pure and Applied Chemistry Standard Methods for the Analysis of Oils, Fats, and Derivatives. Fatty acid composition of adipose tissue was determined by gas chromatography by use of a Varian 3900 GC with a CP-8400 autosampler (Varian, Middleburg, the Netherlands) equipped with a flame ionization detector. Split injection mode, a CP-sil 88 60 mϫ0.25-mm internal diameter capillary column, temperature programming from 90°C to 210°C, and constant flow were used. Helium was used as the carrier gas, and commercially available standards (Nu-Chek-Prep, Inc, Elysian, MN) were used to identify the individual fatty acids. Results were given as percentages of total fatty acids. The interassay coefficients of variation for determination of EPA, DPA, and DHA were 6.1%, 4.2%, and 5.2%, respectively.
At inclusion, participants completed a questionnaire concerning lifestyle and medical history, including information on smoking habits, alcohol consumption, physical activity during leisure time, education, history of diabetes mellitus, and (for women) hormone replacement therapy. The questionnaires were checked by a trained interviewer during a clinical visit. At the same visit, body weight, height, and blood pressure were measured, and biological material, including adipose tissue, was collected.
Identification of cases with ACS has been described in detail elsewhere. 31 Briefly, we identified all participants in the Diet, Cancer and Health cohort who were registered with an incident discharge diagnosis of ACS in the Danish National Patient Registry until January 1, 2004. Medical records were retrieved and reviewed to ensure that all patients fulfilled the criteria of ACS according to current recommendations for epidemiological studies from the American Heart Association and other major health organizations. 32 We also included participants registered in the Causes of Death Registry with ACS as the cause of death without prior registration of incident disease.
Statistical Analyses
We used a case-cohort design including all cases and a sex-stratified cohort sample (subcohort) of 1816 subjects (36 cases) drawn randomly from the whole cohort of 57 053 subjects. The subsample was generated retrospectively to size it according to the power calculation. We used the method of Cai and Zeng 33 for power calculations. Assuming a significance level of 5% and a power of 80%, we would be able to detect a hazard ratio (highest versus lowest quintile) of 0.73 for men and 0.63 for women with the number of cases and subcohort size stated in Table 1 . A Cox proportional hazards model was used for the statistical analyses, as if the full cohort were included, modified by a weighting scheme described by Kalbfleisch and Lawless 34 and using a robust variance estimate. In the case-cohort design, weights were assigned to each subject, one for cases and N/n for noncases in the subcohort, with N (n) being the number of noncases in the cohort (subcohort). For women, N/n was 29 019/851, and for men, N/n was 25 142/929.
Associations were explored for the content of total marine n-3 PUFAs and for EPA, DHA, and DPA separately. Exposure variables were included as continuous variables, and regression coefficients were calculated when the assumptions were fulfilled. Subsequently, data were analyzed categorically and separately for men and women. To achieve the best statistical power, quintiles were defined according to the exposure distribution among cases. We calculated incidence rate ratios using Cox proportional hazards models with age as the time axis, allowing for delayed entry. In multivariable analyses, we adjusted the risk estimates for known risk factors for CHD at baseline: smoking, body mass index, physical activity, education, history of diabetes mellitus, blood pressure, serum cholesterol, and alcohol consumption. For women, we also adjusted for hormone replacement therapy. We decided not to control for potential confounding from diet because the measures of associations from models including diet would be without clear interpretation. Participants for whom information on Ն1 confounders was missing were excluded. We also examined the association between marine n-3 PUFAs in adipose tissue and body mass index. Analyses were performed with Stata version 9.0 (Stata Corp, College Station, TX). Model adequacy was assessed graphically and found to be appropriate in all analyses. 
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In total, 1619 individual from the cohort (Nϭ57 053) were excluded from this study because they had a diagnosis of ACS or cancer before entry into the study or did not fully complete the questionnaires (see the Figure) . We identified 1654 participants in the Cancer, Diet and Health cohort with an incident diagnosis of ACS in the Danish National Patient Registry after recruitment. We were not able to retrieve any medical records or had insufficient information on 103 cases, who were subsequently excluded from the statistical analyses. Of the remaining 1551 cases, 1059 fulfilled the criteria of ACS after review of all records. Twenty cases were excluded because their ACS diagnosis was related to a medical procedure, eg, major surgery. From the Causes of Death Registry, we included 111 cases registered with ACS as the cause of death without prior registration of ACS in the Danish National Patient Registry. The incidence rates for men and women were 0.5 and 0.1 per 1000 years, respectively, and the incidence rate ratio was 3.6 (95% confidence interval, 3.2 to 4.2). We excluded 138 cases and 150 controls from the statistical analyses because insufficient amounts of adipose tissue were available for biochemical analyses (nϭ252) or because information on Ն1 confounders was missing (nϭ36; see the Figure) . This left 1012 cases for final analysis. More than 86% of cases were nonfatal ACS, and only 143 had fatal ACS; for this reason, results are given only for total ACS.
Baseline characteristics of the subcohort and ACS patients are given in Table 1 . There were more current smokers, subjects with systolic blood pressure Ͼ140 mm Hg, patients with diabetes mellitus, patients with higher serum cholesterol levels, and subjects with education Ͻ8 years among cases than in the subcohort. In women, there were also more overweight subjects among cases compared with the subcohort.
We found a significant dose-dependent negative association between the content of total marine n-3 PUFAs in adipose tissue and the incidence of ACS in men (Table 2) . When included as a continuous variable, the regression coefficient was 0.93 (95% confidence interval, 0.88 to 0.98) per 0.1% of marine n-3 PUFAs in adipose tissue. The adjusted hazard ratio for subjects in the highest compared with the lowest quintile was 0.65 (95% confidence interval, 0.45 to 0.95). The association was driven primarily by an underlying association for DHA, but negative associations were also found for EPA and DPA.
No consistent associations were observed in women ( Table  2 ). In addition, no negative association was found between marine n-3 PUFAs in adipose tissue and body mass index.
Discussion
We found a significant monotonic negative association between the content of total marine n-3 PUFAs in adipose tissue and the incidence of ACS among men. A significant negative association was also found between the content of DHA and ACS, whereas the associations for EPA and DPA were negative but not statistically significant. In contrast, we found no consistent associations among women.
Our study had several strengths. We collected adipose tissue biopsies from a large cohort of subjects before diagnosis of disease and determined the content of marine n-3 PUFAs in adipose tissue, which is considered a good longterm marker of dietary intake of these fatty acids. 24, 28 During follow-up, only a few subjects were lost, and a large number of ACS events was registered. All outcome data from the hospital discharge register were validated through review of each medical record to ensure a correct diagnosis of ACS according to current criteria. Moreover, we had information on several potential confounders that we adjusted for in our statistical analyses, but this had no substantial influence on the risk estimates, making residual confounding an unlikely explanation for the study results. We used a case-cohort design because the outcome was rare, and analysis of fatty acid composition in fat tissue is costly and impairs the use of adipose tissue for other purposes.
Our study also had limitations. The age distribution in our study was the same for both sexes, but the number of female cases was substantially lower than that of men, probably because women in general are older when they experience ACS. 35, 36 The confidence intervals were thus wide for women; the power to study potential effect modification from sex was limited; and there were too few cases to allow separate analyses of fatal ACS. Disadvantaged population groups are often underrepresented in cohort studies requiring active participation, which appears to be the case in the Diet, Cancer and Health study. 29 This could minimize the variation in the exposure (the content of marine n-3 PUFAs in adipose tissue) and makes it more difficult to reveal an association between marine n-3 PUFAs and ACS. The level of marine n-3 PUFAs in adipose tissue was low and the interindividual differences were limited. This may have limited the possibilities to reveal an association between marine n-3 PUFAs and 
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ACS. Unfortunately, we did not have access to plasma or cells (eg, red cells), so we were unable to compare the content of n-3 PUFAs in adipose tissue with that in plasma or cells. The content of marine n-3 PUFAs in adipose tissue depends not only on dietary intake but also on conversion from other fatty acids and on the metabolism and distribution of fatty acids into different tissues in the body. However, humans can convert ␣-linolenic acid, a shorter essential n-3 PUFAs mainly derived from plants, into EPA and DPA to only a very limited degree, and the conversion to DHA is even smaller. We excluded all participants with ACS before the study period but not participants with other cardiovascular diseases who were at increased risk of ACS. Ascertainment of a disease may lead to a change to a healthier diet, including an increase in the intake of seafood. We may therefore have underestimated the association between the content of marine n-3 PUFAs in adipose tissue and the risk of ACS.
We did not have information on medication and thus were not able to adjust for the use of, for example, statins or aspirin. However, we adjusted for total cholesterol and blood pressure and found that further adjustment for medication would only affect the associations to a minor degree.
The stated P values and confidence limits have not been corrected for multiple testing, as preferred by Perneger 37 and Rothman, 38 but type I errors may be inflated.
Marine n-3 PUFAs are incorporated into cell membrane phospholipids, where they may affect membrane function, cell signaling, arrhythmic properties, and a variety of other processes. 5, 6, 18, 39 These mechanisms may explain a possible antithrombotic 11, 40 and/or antiarrhythmic 5, 12, 15, 41 effect of marine n-3 PUFAs on the reduced risk of ACS. In addition, a stabilizing (antiinflammatory) effect of marine n-3 PUFAs on human atherosclerotic plaques has been reported 42 that may decrease the risk of plaque rupture and thus ACS. Finally, marine n-3 PUFAs also lower plasma triglycerides, impair platelet and leukocyte reactivity, lower heart rate, and may slightly reduce blood pressure. 5, 20, 39, 43 The mechanisms by which n-3 PUFAs reduced ACS in men in the present study are uncertain. We observed a difference in the risk of ACS between groups, with small detectable differences in n-3 PUFAs in adipose tissue with very low levels of these fatty acids. Other epidemiological studies have also found differences in ACS risk between groups with even small differences in intake of n-3. 3, 7, 16 In our study, the content of DHA in adipose tissue was more strongly associated with the ACS risk than the levels of EPA and DPA. This may reflect special properties of DHA, or it may be that adipose DHA is an adequate marker of dietary intake of fish and total marine n-3 PUFAs.
Previous observational epidemiological studies and randomized trials [3] [4] [5] 12, 18, 22, 23, 40 have reported beneficial effects of dietary intake of fish and marine n-3 PUFAs on the risk of fatal MI, especially among subjects already diagnosed with CHD. The results concerning the risk of nonfatal MI and ACS, however, have been conflicting. 11, 13, 16, 17, 21, 43, 44, 45 We found a negative association between the total marine n-3 PUFA (and DHA) content in adipose tissue and the risk of ACS. Most cases (86%) were nonfatal ACS cases. Thus, our results indicate that marine n-3 fatty acids are important, and the clear associations found in this study compared with previous studies may reflect high-quality exposure and outcome assessment.
Other studies have reported negative associations between the intake of marine n-3 PUFAs and the risk of ACS in women, 3 but no association between marine n-3 PUFAs and the risk of ACS was observed in our study. The ACS incidence rates for men and women differed in our study, indicating that there may be sex differences in the risk factors HR indicates hazard ratio; CI, confidence interval; ACS, acute coronary syndrome; PUFAs, polyunsaturated fatty acids; EPA, eicosapentaenoic acid; DPA, docosapentaenoic acid; and DHA, docosahexaenoic acid.
*Adjusted for smoking, body mass index, time of moderate to vigorous physical activity, history of diabetes mellitus, systolic blood pressure, total cholesterol, education, and alcohol consumption. Analyses in women were also adjusted for hormone replacement therapy.
for or presentation of ACS and raising the possibility of sex differences in the effect of marine n-3 PUFAs. Importantly, the number of women with ACS was rather low in our study.
Different methods to determine dietary intake of marine n-3 PUFAs may help explain the different results in previous studies. Biomarker studies may have advantages compared with studies using data from food frequency questionnaires because these measures are less prone to recall bias. Harris and von Schacky 46 have introduced the term Omega-3 Index, which is the content of marine n-3 PUFAs in red blood cell membranes, and have reported that subjects with an Omega-3 Index Ͻ4% were at increased risk of ACS compared with subjects with a higher index. 21, 23, 46, 47 Another case-control study, however, could not confirm this finding. 48 Red blood cells were not available for analysis in this study, so we were unable to provide further information on this issue.
Other case-control studies have examined the impact of the content of marine n-3 PUFAs in adipose tissue on CHD risk and reported a significantly lower content of marine n-3 PUFAs 49 or DHA 50 in adipose tissue among incident cases with MI or angina pectoris compared with controls. Thus, in the European Multicenter Case Control Study on Antioxidants, Myocardial Infarction and Cancer of the Breast (EURAMIC), which included 639 male cases with incident MI and 700 healthy controls, Guallar et al 51 found a significant trend toward a lower risk of MI with higher DHA levels in adipose tissue. Fat mass may differ between subjects, and overweight individuals may potentially have lower relative levels of marine n-3 PUFAs in adipose tissue. We therefore examined the association between marine n-3 PUFAs in adipose tissue and body mass index but found no negative association.
Conclusions
The risk of ACS was lower in men with a higher content of total and individual marine n-3 PUFAs in adipose tissue. This suggests that intake of seafood may protect against ACS. The results in women were inconsistent, and further studies are warranted to clarify the association between marine n-3 PUFAs and ACS in women.
